{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:17:30Z","timestamp":1793823450071,"version":"4.6.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703757, 81874210, 81874319"],"award-info":[{"award-number":["81703757, 81874210, 81874319"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703757, 81874210, 81874319"],"award-info":[{"award-number":["81703757, 81874210, 81874319"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703757, 81874210, 81874319"],"award-info":[{"award-number":["81703757, 81874210, 81874319"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The liposoluble tanshinones are bioactive components in<jats:italic>Salvia miltiorrhiza<\/jats:italic>and are widely investigated as anti-cancer agents, while the molecular mechanism is to be clarified. In the present study, we identified that the human fragile histidine triad (FHIT) protein is a direct binding protein of sodium tanshinone IIA sulfonate (STS), a water-soluble derivative of Tanshinone IIA (TSA), with a Kd value of 268.4\u2009\u00b1\u200942.59\u00a0nM. We also found that STS inhibited the diadenosine triphosphate (Ap3A) hydrolase activity of FHIT through competing for the substrate-binding site with an IC<jats:sub>50<\/jats:sub>value of 2.2\u2009\u00b1\u20090.05\u00a0\u00b5M. Notably, near 100 times lower binding affinities were determined between STS and other HIT proteins, including GALT, DCPS, and phosphodiesterase ENPP1, while no direct binding was detected with HINT1. Moreover, TSA, Tanshinone I (TanI), and Cryptotanshinone (CST) exhibited similar inhibitory activity as STS. Finally, we demonstrated that depletion of FHIT significantly blocked TSA\u2019s pro-apoptotic function in colorectal cancer HCT116 cells. Taken together, our study sheds new light on the molecular basis of the anti-cancer effects of the tanshinone compounds.<\/jats:p>","DOI":"10.1038\/s41598-021-91708-z","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T10:16:45Z","timestamp":1623233805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tanshinones induce tumor cell apoptosis via directly targeting FHIT"],"prefix":"10.1038","volume":"11","author":[{"given":"Xianglian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"91708_CR1","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.286.19.2441","volume":"286","author":"H Ishii","year":"2001","unstructured":"Ishii, H. Potential cancer therapy with the FHIT gene review of the preclinical studies. JAMA 286, 2441 (2001).","journal-title":"JAMA"},{"key":"91708_CR2","doi-asserted-by":"publisher","first-page":"11529","DOI":"10.1021\/bi961415t","volume":"35","author":"LD Barnes","year":"1996","unstructured":"Barnes, L. D. et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5\u2019,5\u2019\u2019\u2019-P1, P3-triphosphate hydrolase. Biochemistry 35, 11529\u201311535 (1996).","journal-title":"Biochemistry"},{"key":"91708_CR3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/protein\/10.12.1461","volume":"10","author":"C Brenner","year":"1997","unstructured":"Brenner, C. Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein. Protein Eng. 10, 1461\u20131463 (1997).","journal-title":"Protein Eng."},{"key":"91708_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.278.5336.286","volume":"278","author":"CD Lima","year":"1997","unstructured":"Lima, C. D., Klein, M. G. & Hendrickson, W. A. Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science 278, 286\u2013293 (1997).","journal-title":"Science"},{"key":"91708_CR5","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.1073\/pnas.94.25.13771","volume":"94","author":"Z Siprashvlli","year":"1997","unstructured":"Siprashvlli, Z. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. U S A 94, 13771\u201313776 (1997).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"91708_CR6","first-page":"3333","volume":"59","author":"L Ji","year":"1999","unstructured":"Ji, L. et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res. 59, 3333\u20133339 (1999).","journal-title":"Cancer Res."},{"key":"91708_CR7","first-page":"5484","volume":"95","author":"HC Pace","year":"1998","unstructured":"Pace, H. C. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Biochem. J. 95, 5484\u20135489 (1998).","journal-title":"Biochem. J."},{"issue":"4","key":"91708_CR8","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1073\/pnas.0437915100","volume":"100","author":"F Trapasso","year":"2003","unstructured":"Trapasso, F. et al. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding. Proc. Natl. Acad. Sci. U S A 100(4), 1592\u20131597 (2003).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"91708_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/onc.2009.418","volume":"29","author":"A Joannes","year":"2010","unstructured":"Joannes, A. et al. Fhit regulates invasion of lung tumor cells. Oncogene 29(8), 1203\u20131213 (2010).","journal-title":"Oncogene"},{"issue":"5","key":"91708_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1158\/1541-7786.MCR-13-0386-T","volume":"12","author":"A Joannes","year":"2014","unstructured":"Joannes, A. et al. Fhit regulates EMT targets through an EGFR\/Src\/ERK\/Slug signaling axis in human bronchial cells. Mol. Cancer Res. 12(5), 775\u2013783 (2014).","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"91708_CR11","doi-asserted-by":"publisher","first-page":"e1004652","DOI":"10.1371\/journal.pgen.1004652","volume":"10","author":"SS Suh","year":"2014","unstructured":"Suh, S. S. et al. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. PLoS Genet. 10(10), e1004652 (2014).","journal-title":"PLoS Genet."},{"issue":"13","key":"91708_CR12","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.yexcr.2006.04.004","volume":"312","author":"Y Nakagawa","year":"2006","unstructured":"Nakagawa, Y. & Akao, Y. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines. Exp. Cell Res. 312(13), 2433\u20132442 (2006).","journal-title":"Exp. Cell Res."},{"issue":"21","key":"91708_CR13","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1158\/0008-5472.CAN-07-0677","volume":"67","author":"G Jayachandran","year":"2007","unstructured":"Jayachandran, G. et al. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras\/Rho GTPase molecular switch. Cancer Res. 67(21), 10379\u201310388 (2007).","journal-title":"Cancer Res."},{"issue":"23","key":"91708_CR14","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1007\/s00018-014-1722-0","volume":"71","author":"CE Waters","year":"2014","unstructured":"Waters, C. E. et al. The FHIT gene product: Tumor suppressor and genome \u201ccaretaker\u201d. Cell Mol. Life Sci. 71(23), 4577\u20134587 (2014).","journal-title":"Cell Mol. Life Sci."},{"issue":"18","key":"91708_CR15","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.4161\/15384101.2014.946858","volume":"13","author":"JA Boylston","year":"2014","unstructured":"Boylston, J. A. & Brenner, C. A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1. Cell Cycle 13(18), 2913\u20132930 (2014).","journal-title":"Cell Cycle"},{"issue":"3","key":"91708_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41419-019-1414-7","volume":"10","author":"T Druck","year":"2019","unstructured":"Druck, T. et al. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells. Cell Death Dis. 10(3), 147 (2019).","journal-title":"Cell Death Dis."},{"key":"91708_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0014-5793(98)00579-1","volume":"429","author":"P Rotlla\u00e8n","year":"1998","unstructured":"Rotlla\u00e8n, P., Rodr\u00edguez-Ferrer, C. R., Asensio, A. C. & Oaknin, S. Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin. FEBS Lett. 429, 143\u2013146 (1998).","journal-title":"FEBS Lett."},{"issue":"1","key":"91708_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0008-6363(99)00004-8","volume":"42","author":"NA Flores","year":"1999","unstructured":"Flores, N. A., Stavrou, B. M. & Sheridan, D. J. The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc. Res. 42(1), 15\u201326 (1999).","journal-title":"Cardiovasc. Res."},{"issue":"38","key":"91708_CR19","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.1002\/anie.201405259","volume":"53","author":"SM Hacker","year":"2014","unstructured":"Hacker, S. M. et al. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit. Angew. Chem. Int. Ed. Engl. 53(38), 10247\u201310250 (2014).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"17","key":"91708_CR20","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/cbic.201700226","volume":"18","author":"S Lange","year":"2017","unstructured":"Lange, S. et al. Small-molecule inhibitors of the tumor suppressor Fhit. ChemBioChem 18(17), 1707\u20131711 (2017).","journal-title":"ChemBioChem"},{"issue":"8","key":"91708_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.tibs.2018.06.003","volume":"43","author":"C Cui","year":"2018","unstructured":"Cui, C. et al. Is beta-catenin a druggable target for cancer therapy?. Trends Biochem. Sci. 43(8), 623\u2013634 (2018).","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"91708_CR22","first-page":"163","volume":"13","author":"CY Su","year":"2015","unstructured":"Su, C. Y. et al. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. Chin. J. Nat. Med. 13(3), 163\u2013182 (2015).","journal-title":"Chin. J. Nat. Med."},{"key":"91708_CR23","doi-asserted-by":"publisher","first-page":"110599","DOI":"10.1016\/j.biopha.2020.110599","volume":"130","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases. Biomed. Pharmacother 130, 110599 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"91708_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2019.00202","volume":"10","author":"Z Jiang","year":"2019","unstructured":"Jiang, Z., Gao, W. & Huang, L. Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza. Front Pharmacol 10, 202 (2019).","journal-title":"Front Pharmacol"},{"key":"91708_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.611087","author":"ZY Fang","year":"2021","unstructured":"Fang, Z. Y. et al. Tanshinone IIA: A review of its anticancer effects. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.611087 (2021).","journal-title":"Front. Pharmacol."},{"key":"91708_CR26","first-page":"716459","volume":"2012","author":"Q Shang","year":"2012","unstructured":"Shang, Q., Xu, H. & Huang, L. Tanshinone IIA: A promising natural cardioprotective agent. Evid. Based Compl. Altern. Med. 2012, 716459 (2012).","journal-title":"Evid. Based Compl. Altern. Med."},{"key":"91708_CR27","doi-asserted-by":"publisher","first-page":"105364","DOI":"10.1016\/j.phrs.2020.105364","volume":"164","author":"MA Ansari","year":"2021","unstructured":"Ansari, M. A. et al. Prospective therapeutic potential of Tanshinone IIA: An updated overview. Pharmacol Res. 164, 105364 (2021).","journal-title":"Pharmacol Res."},{"key":"91708_CR28","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/DDDT.S266911","volume":"14","author":"R Guo","year":"2020","unstructured":"Guo, R. et al. Pharmacological activity and mechanism of Tanshinone IIA in related diseases. Drug Des. Dev. Ther. 14, 4735\u20134748 (2020).","journal-title":"Drug Des. Dev. Ther."},{"issue":"5","key":"91708_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41419-020-2579-9","volume":"11","author":"M Li","year":"2020","unstructured":"Li, M. et al. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis. Cell Death Dis. 11(5), 381 (2020).","journal-title":"Cell Death Dis."},{"issue":"2","key":"91708_CR30","first-page":"1692","volume":"18","author":"L He","year":"2018","unstructured":"He, L. & Gu, K. Tanshinone IIA regulates colorectal cancer apoptosis via attenuation of Parkin-mediated mitophagy by suppressing AMPK\/Skp2 pathways. Mol. Med. Rep. 18(2), 1692\u20131703 (2018).","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"91708_CR31","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1002\/ptr.6392","volume":"33","author":"XZ Liao","year":"2019","unstructured":"Liao, X. Z. et al. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase\/Akt signalling pathway. Phytother. Res. 33(9), 2298\u20132309 (2019).","journal-title":"Phytother. Res."},{"issue":"5","key":"91708_CR32","first-page":"2995","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K\/Akt pathway. Am. J. Transl. Res. 11(5), 2995\u20133006 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"91708_CR33","unstructured":"Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease. A double blind study. Shanghai Cooperative Group for the Study of Tanshinone IIA. J. Trad. Chin. Med. 4(1), 20\u201324 (1984)."},{"key":"91708_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fphar.2020.00687","volume":"11","author":"YR Bao","year":"2020","unstructured":"Bao, Y. R. et al. Sodium Tanshinone II sulfonate A ameliorates hypoxia-induced pulmonary hypertension. Front. Pharmacol. 11, 687 (2020).","journal-title":"Front. Pharmacol."},{"key":"91708_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biopha.2018.12.019","volume":"111","author":"XX Li","year":"2019","unstructured":"Li, X. X. et al. Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation. Biomed. Pharmacother. 111, 68\u201375 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"91708_CR36","doi-asserted-by":"publisher","first-page":"6712585","DOI":"10.1155\/2018\/6712585","volume":"2018","author":"T Chen","year":"2018","unstructured":"Chen, T. et al. Sodium Tanshinone IIA sulfonate prevents angiotensin II-induced differentiation of human atrial fibroblasts into myofibroblasts. Oxid. Med. Cell Longev. 2018, 6712585 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"91708_CR37","doi-asserted-by":"publisher","first-page":"15137","DOI":"10.1038\/s41598-018-33552-2","volume":"8","author":"D Han","year":"2018","unstructured":"Han, D. et al. Sodium tanshinone IIA sulfonate protects ARPE-19 cells against oxidative stress by inhibiting autophagy and apoptosis. Sci. Rep. 8(1), 15137 (2018).","journal-title":"Sci. Rep."},{"key":"91708_CR38","doi-asserted-by":"publisher","first-page":"109362","DOI":"10.1016\/j.biopha.2019.109362","volume":"118","author":"ZY Zhou","year":"2019","unstructured":"Zhou, Z. Y. et al. Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics. Biomed. Pharmacother. 118, 109362 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"91708_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ncomms1093","volume":"1","author":"CJ Wienken","year":"2010","unstructured":"Wienken, C. J. et al. Protein-binding assays in biological liquids using microscale thermophoresis. Nat. Commun. 1, 100 (2010).","journal-title":"Nat. Commun."},{"issue":"33","key":"91708_CR40","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1073\/pnas.1604520113","volume":"113","author":"Y Qu","year":"2016","unstructured":"Qu, Y. et al. Axitinib blocks Wnt\/\u03b2-catenin signaling and directs asymmetric cell division in cancer. Proc. Natl. Acad. Sci. U S A 113(33), 9339\u20139344 (2016).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"91708_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0969-2126(97)00231-1","volume":"5","author":"CD Lima","year":"1997","unstructured":"Lima, C. D. et al. MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family. Structure 5(6), 763\u2013774 (1997).","journal-title":"Structure"},{"issue":"6","key":"91708_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.bbabio.2011.02.001","volume":"1807","author":"J Martin","year":"2011","unstructured":"Martin, J., St-Pierre, M. V. & Dufour, J. F. Hit proteins, mitochondria and cancer. Biochim Biophys Acta 1807(6), 626\u2013632 (2011).","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"91708_CR43","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1074\/jbc.M113.505867","volume":"289","author":"RA Albright","year":"2014","unstructured":"Albright, R. A. et al. Molecular basis of purinergic signal metabolism by ectonucleotide pyrophosphatase\/phosphodiesterases 4 and 1 and implications in stroke. J. Biol. Chem. 289(6), 3294\u20133306 (2014).","journal-title":"J. Biol. Chem."},{"key":"91708_CR44","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2174\/0929867327666200521124850","volume":"28","author":"Z Lai","year":"2020","unstructured":"Lai, Z. et al. Tanshinones: An update in the medicinal chemistry in recent 5 years. Curr. Med. Chem. 28, 2807\u20132827 (2020).","journal-title":"Curr. Med. Chem."},{"key":"91708_CR45","first-page":"4555","volume":"275","author":"A Draganescu","year":"2000","unstructured":"Draganescu, A. Fhit-nucleotide specificity probed with novel fluorescent and fluorogenic substrates. Biochem. J. 275, 4555\u20134560 (2000).","journal-title":"Biochem. J."},{"key":"91708_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00193","author":"L Fu","year":"2020","unstructured":"Fu, L. et al. The Anticancer Properties of Tanshinones and the pharmacological effects of their active ingredients. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.00193 (2020).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"91708_CR47","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/sj.bjc.6602058","volume":"91","author":"M Ottey","year":"2004","unstructured":"Ottey, M. et al. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant. Br. J. Cancer 91(9), 1669\u20131677 (2004).","journal-title":"Br. J. Cancer"},{"issue":"2","key":"91708_CR48","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/cancers6021208","volume":"6","author":"JR Karras","year":"2014","unstructured":"Karras, J. R., Paisie, C. A. & Huebner, K. Replicative stress and the FHIT gene: Roles in tumor suppression, genome stability and prevention of carcinogenesis. Cancers (Basel) 6(2), 1208\u20131219 (2014).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"91708_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/1873-3468.12560","volume":"591","author":"A Krakowiak","year":"2017","unstructured":"Krakowiak, A. et al. New interactions between tumor suppressor Fhit protein and a nonhydrolyzable analog of its AP4 A substrate. FEBS Lett. 591(3), 548\u2013559 (2017).","journal-title":"FEBS Lett."},{"key":"91708_CR50","doi-asserted-by":"publisher","first-page":"110599","DOI":"10.1016\/j.biopha.2020.110599","volume":"130","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases. Biomed. Pharmacother. 130, 110599 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"91708_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03434-z","author":"M Li","year":"2021","unstructured":"Li, M. et al. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-021-03434-z (2021).","journal-title":"Cell Death Dis."},{"key":"91708_CR52","doi-asserted-by":"publisher","first-page":"586616","DOI":"10.3389\/fphar.2020.586616","volume":"11","author":"Q Song","year":"2020","unstructured":"Song, Q. et al. Tanshinone IIA inhibits epithelial-to-mesenchymal transition through hindering beta-arrestin1 mediated beta-catenin signaling pathway in colorectal cancer. Front. Pharmacol. 11, 586616 (2020).","journal-title":"Front. Pharmacol."},{"key":"91708_CR53","doi-asserted-by":"publisher","first-page":"40382","DOI":"10.1038\/srep40382","volume":"7","author":"ST Huang","year":"2017","unstructured":"Huang, S. T. et al. Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction. Sci. Rep. 7, 40382 (2017).","journal-title":"Sci. Rep."},{"key":"91708_CR54","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.2147\/OTT.S246606","volume":"13","author":"F Gao","year":"2020","unstructured":"Gao, F. et al. Inhibition of EGFR signaling and activation of mitochondrial apoptosis contribute to Tanshinone IIA-mediated tumor suppression in non-small cell lung cancer cells. Onco Targets Ther. 13, 2757\u20132769 (2020).","journal-title":"Onco Targets Ther."},{"issue":"6","key":"91708_CR55","first-page":"534","volume":"12","author":"MZ Liu","year":"1991","unstructured":"Liu, M. Z., Huang, Y. S. & Xiao, W. Q. No promoting effects of sodium tanshinone II-A sulfonate on growth and metastasis of Lewis carcinoma. Zhongguo Yao Li Xue Bao 12(6), 534\u2013537 (1991).","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"91708_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2017.05.013","volume":"403","author":"H Sui","year":"2017","unstructured":"Sui, H. et al. Tanshinone IIA inhibits \u03b2-catenin\/VEGF-mediated angiogenesis by targeting TGF-\u03b21 in normoxic and HIF-1\u03b1 in hypoxic microenvironments in human colorectal cancer. Cancer Lett. 403, 86\u201397 (2017).","journal-title":"Cancer Lett."},{"issue":"22","key":"91708_CR57","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1182\/blood-2012-04-425215","volume":"120","author":"RA Albright","year":"2012","unstructured":"Albright, R. A. et al. NPP4 is a procoagulant enzyme on the surface of vascular endothelium. Blood 120(22), 4432\u20134440 (2012).","journal-title":"Blood"},{"issue":"19","key":"91708_CR58","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.1822026116","volume":"116","author":"X Ji","year":"2019","unstructured":"Ji, X. et al. Alarmone Ap4A is elevated by aminoglycoside antibiotics and enhances their bactericidal activity. Proc. Natl. Acad. Sci. U S A 116(19), 9578\u20139585 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"21","key":"91708_CR59","doi-asserted-by":"publisher","first-page":"eaax3333","DOI":"10.1126\/sciadv.aax3333","volume":"6","author":"J Guerra","year":"2020","unstructured":"Guerra, J. et al. Lysyl-tRNA synthetase produces diadenosine tetraphosphate to curb STING-dependent inflammation. Sci. Adv. 6(21), eaax3333 (2020).","journal-title":"Sci. Adv."},{"issue":"2","key":"91708_CR60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"issue":"1","key":"91708_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470559277.ch090102","volume":"1","author":"NJ Moerke","year":"2009","unstructured":"Moerke, N. J. Fluorescence polarization (FP) assays for monitoring peptide-protein or nucleic acid-protein binding. Curr. Protoc. Chem. Biol. 1(1), 1\u201315 (2009).","journal-title":"Curr. Protoc. Chem. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91708-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:07:45Z","timestamp":1699121265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91708-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["91708"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-91708-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12217"}}